Skip to content. | Skip to navigation

Personal tools
Sections
You are here: Home

Did you not find what you were looking for? Try the Advanced Search to refine your search.

Search results 92 items matching your search terms

Subscribe to an always-updated feed of these search terms

Pharmaceuticals Guides
Guides on the EU Pharmaceuticals policy.
European Drug Report 2018: Trends and Developments
Evidence of increased cocaine availability is highlighted by the EU drugs agency (EMCDDA) in its European Drug Report 2018. The report provides a comprehensive ...
Drugs report highlights resurgence of cocaine in Europe
The European Drug Report 2018, issued by the EU drugs agency Thursday, highlights increased availability of cocaine in Europe, with around 2.3 million young ...
New safety features for medicines sold in the EU
As of 9 February 2019, the new rules on safety features for prescription medicines sold in the EU will apply.
Falsified medicines are often disguised as authentic medicines but may contain ingredients of bad or toxic quality, or in the wrong dosage. As they have not ...
New EU rules on fake drugs enter into force
New rules on safety features for prescription medicines sold in the EU entered into force Saturday, heralding the introduction of end-to-end verification and ...
Brussels mulls new initiative on antimicrobial resistance
The EU Commission launched a public consultation Friday on possible activities to include in a new action plan to combat antimicrobial resistance (AMR) it ...
EU proposes ban on new psychoactive substance
The European Commission proposed Wednesday to subject the new psychoactive substance MDMB-CHMICA, sometimes referred to as 'Black Mamba', to control measures ...
Action against Cancer: A European Partnership - briefing
The European Commission on 24 June set up a European Partnership for Action against Cancer, reinforcing its long-term commitment to the fight against cancer. ...
As news reaches the public about the spread of H5N1 'avian' influenza virus from Asia to Europe and Africa, it raises some questions. What is the difference ...
Faster access to better medicines: the Innovative Medicines Initiative
Proposed on 15 May 2007 by the European Commission, the Innovative Medicines Initiative (IMI) seeks to overcome research bottlenecks in the drug development ...
EU Pharmaceutical Regulation
This book provides an analysis of European Union pharmaceutical regulation from a policy-making perspective. It focuses on how the conflicting agendas of the ...
Regulating Medicines in Europe
This Book explains and investigates how medicines are controlled in Europe, especially the EU. Based on penetrating documentary and interview research with the ...
EU, US agree pharmaceuticals mutual recognition
The EU and the United States have completed a Mutual Recognition Agreement, with both sides agreeing to reduce barriers and increase trade in pharmaceuticals ...
Complaints, Complainants, and Rulings Regarding Drug Promotion in the United Kingdom and Sweden 2004–2012
In many European countries, medicines promotion is governed by voluntary codes of practice administered by the pharmaceutical industry under its own system of ...
The European Drug Report 2015: Trends and Developments
Changing dynamics in the heroin market, the latest implications of cannabis use and new features and dimensions of the stimulant and 'new drugs' scene are ...
European Drug Report 2019: Trends and Developments
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well ...
Cheaper drugs incentive schemes ruled legal by European court
The European Court of Justice has ruled that public authorities may offer financial incentives to induce doctors to prescribe cheaper medicinal products.
Pharmaceuticals companies
Pharmaceuticals companies in Europe
Boost for joint European assessment of medicines
A new law adopted by the European Parliament on Wednesday aims to avoid duplicating national assessments to determine a medicine's added value that help EU ...
Ehe EU Directive on Dangerous Substances was a response to a need to ensure the protection of public health, in particular the health of workers handling ...
Pharmaceuticals
The role of the European Commission is to ensure that all players on the pharmaceuticals market (EU Member States, national health services and pharmaceutical ...
The European cosmetics industry has a value of output of more than EUR 35 billion; is highly innovative, with major cosmetic companies replacing or ...
Fees for Pharmacovigilance activities
The European Parliament voted on 16 April in favour of an EU Regulation on fees payable to the European Medicines Agency (EMA) for the conduct of ...
From 22 March 2011, all EU citizens have access to information on the thousands of authorised pharmaceutical clinical trials that are under way in the EU. The ...
European Medicines Agency user guide for SMEs
The guide aims to support SMEs to better understand the EU legislative framework relating to medicines and the requirements for the development and ...
CASELEX:EU:2003:187 - European Court of Justice, European Union Consumer Protection Law, ICT And Media Law
European Court of Justice, European Union Consumer Protection Law, ICT And Media Law
CASELEX:EU:2008:92 - IP Law - Trade marks - Pharmaceutical products
The reference was made by the Oberster Gerichtshof (Austria) in the course of proceedings between The Wellcome Foundation Ltd (‘Wellcome’), proprietor of the ...
Incentive driven pharmaceutical prescription is lawful, EU Court rules
The European Court of Justice has ruled that public authorities may offer financial incentives to induce doctors to prescribe cheaper medicinal products. ...
EU pharma waiver to boost generic drugs exports
The EU Commission proposed Monday to adjust intellectual property rules to help Europe's pharmaceutical companies tap into fast-growing global markets and ...
EU Alerts

EUbusiness Week no. 849
A Commission to tackle the crises?
→ EUbusiness Week archive

The Week Ahead no. 445
Transport and climate change - accessible cities - next ECB president - Brexit - foreign electoral interference in Europe

Subscription options